Doxorubicin Toxicity can be Ameliorated during Antioxidant L-Carnitine Supplementation

Doxorubicin is an antibiotic broadly used in treatment of different types of solid tumors. The present study investigates whether L-carnitine, antioxidant agent, can reduce the hepatic damage induced by doxorubicin. Male Wistar albino rats were divided into six groups: group 1 was intraperitoneal in...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshabanah, Othman A., Hafez, Mohamed M., Al-Harbi, Mohamed M., Hassan, Zeinab K., Al Rejaie, Salim S., Asiri, Yosef A., Sayed-Ahmed, Mohamed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154045/
https://www.ncbi.nlm.nih.gov/pubmed/21307642
http://dx.doi.org/10.4161/oxim.3.6.14416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154045/
https://www.ncbi.nlm.nih.gov/pubmed/21307642
http://dx.doi.org/10.4161/oxim.3.6.14416

Ejemplares similares